New research by Flinders University has uncovered a potential marker that could provide valuable insights into the overall health of older adults living in long-term aged care facilities.
Aldeyra suffers rejection in rare eye cancer due to ‘lack of substantial evidence’ but seeks use under Expanded Access
The FDA has rejected Aldeyra’s bid for approval in a rare, aggressive type of eye cancer for which the company didn’t conduct any clinical trials.
June 22, 2023